CDC, FDA Expand Eligibility for COVID-19 Booster Shots to Ages 5-11

Following the U.S. Food and Drug Administration’s (FDA) emergency use authorization, the U.S. Centers for Disease Control and Prevention (CDC) is expanding eligibility of the COVID-19 booster doses to children ages five and older. CDC now recommends children ages five to 11 should receive a booster shot five months after their initial Pfizer-BioNTech series.

Additionally, CDC is strengthening its recommendation for a second booster at least four months after the first booster for everyone ages 50 and older and ages 12 and older who are immunocompromised.

Since the pandemic began, more than 4.8 million children ages 5-11 have been diagnosed with COVID and more than 180 have died nationwide. In Louisiana, 180,141 children ages five to 11 have been diagnosed with COVID and 21 children under 18 have died. As of May 19, total COVID cases in Louisiana have increased nearly 568% over the past month.

“We welcome these clear, evidence-based recommendations from the CDC: everyone five and up should be vaccinated and boosted. Everyone 50 and up and everyone 12 and up with immunosuppressive conditions should go further and receive a second booster. This is all the more important as we unfortunately see COVID-19 cases rising again throughout Louisiana. As families prepare for summer activities and the upcoming school year, now is the time to make sure your child is up to date on their vaccinations,” said State Health Officer Joseph Kanter, MD.

 

05/23/2022